Atovaquone/proguanil
Alternative Names: Atovaquone and proguanil hydrochloride; Atovaquone/chloroguanide; Malanil; Malarone; Malarone® Paediatric; Proguanil hydrochloride/atovaquone; Proguanil/atovaquoneLatest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antimalarials; Biguanides; Naphthoquinones
- Mechanism of Action Electron transport complex I inhibitors; Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Malaria
Most Recent Events
- 11 Jun 2013 Launched prior to this date for Malaria in Australia (PO)
- 11 Jun 2013 Launched prior to this date for Malaria in Chile (PO)
- 11 Jun 2013 Launched prior to this date for Malaria in Hong Kong (PO)